case_images: PMC3350113_01
case_images: Prostate adenocarcinoma from biopsy (hematoxylin and eosin, 200x).
case_images: CRIM.ONCMED2011-864371.001.jpg
case_images: PMC3350113_01_CRIM.ONCMED2011-864371.001.jpg
case_images: fig1
case_images: The patient was a 68-year-old human-immunodeficiency virus- (HIV-) negative African-American male who presented for consideration of radiation therapy for prostate cancer: clinical stage T1c, Gleason score 4 + 3 = 7 (Figures 1 and 2), prostate specific antigen (PSA) 14.5 nanogram/deciliter.
case_images: Prostate adenocarcinoma from biopsy (hematoxylin and eosin, 400x).
case_images: CRIM.ONCMED2011-864371.002.jpg
case_images: PMC3350113_01_CRIM.ONCMED2011-864371.002.jpg
case_images: fig2
case_images: The patient was a 68-year-old human-immunodeficiency virus- (HIV-) negative African-American male who presented for consideration of radiation therapy for prostate cancer: clinical stage T1c, Gleason score 4 + 3 = 7 (Figures 1 and 2), prostate specific antigen (PSA) 14.5 nanogram/deciliter.
case_images: Squamous cell carcinoma in situ of the anus with underlying invasion from biopsy (hematoxylin and eosin, 200x).
case_images: CRIM.ONCMED2011-864371.003.jpg
case_images: PMC3350113_01_CRIM.ONCMED2011-864371.003.jpg
case_images: fig3
case_images: Evaluation via physical exam, colonoscopy, and biopsy revealed a 1.5 centimeter invasive squamous cell carcinoma (Figure 3) at the anorectal junction.